GlassScriptPhysician profile
Peggy Ferguson
NPI 1770749913
$8,515.56
in general payments reported to CMS, 2019-2025
40 companies · $1,639 in 2025
The $1,639 reported for 2025 was more than what 93% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,834 · 2022: $1,683 · 2023: $1,663 · 2024: $1,696 · 2025: $1,639.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,998.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,997.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,535.66 | 2021-2025 | |
| Novo Nordisk INC | $1,204.32 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $855.87 | 2021-2025 | Brilinta, Farxiga |
| Lilly USA, LLC | $840.57 | 2021-2025 | Mounjaro, Zepbound, Trulicity |
| Pfizer INC. | $572.01 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $331.87 | 2021-2025 | Jardiance, Tradjenta, Synjardy |
| Astellas Pharma US INC | $304.26 | 2022-2025 | Veozah, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $297.42 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $195.66 | 2021-2024 | Eliquis, Camzyos |
| Exact Sciences Corporation | $195.38 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Daiichi Sankyo INC. | $160.93 | 2021-2023 | Injectafer |
| Corcept Therapeutics | $160.32 | 2024-2025 | Korlym |
| Novartis Pharmaceuticals Corporation | $160.15 | 2021-2024 | |
| Amgen INC. | $153.48 | 2021-2025 | Evenity, Prolia |
| Glaxosmithkline, LLC. | $151.85 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peggy Ferguson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.